NCT02228642

Brief Summary

Patients with diabetes who develop low blood sugars (hypoglycemia) in the hospital are at risk for losing the ability to develop symptoms that warn them that they are having a low blood sugar. There is almost no available information investigating how the inability to feel symptoms of a low blood sugar contributes to the risk of this happening when people with diabetes are hospitalized. The purpose of this study is to develop a symptom score model that will help to identify patients at risk for low blood sugars in the hospital and to examine what happens to patients who do experience a low blood sugar in the hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

August 27, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 29, 2014

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

September 7, 2018

Status Verified

September 1, 2018

Enrollment Period

1.3 years

First QC Date

August 27, 2014

Last Update Submit

September 5, 2018

Conditions

Keywords

Type 1 diabetesType 2 diabetesHypoglycemiaCognition disordersInpatient

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Hypoglycemia Associated Autonomic Failure in the inpatient setting as assessed by hypoglycemia symptom scores

    Hypoglycemia Symptom Score Questionnaires will be administered to participants in time frame described. These questionnaires include a list of potential autonomic and neuroglycopenic symptoms that can occur in response to hypoglycemia.

    Within 24-36 hours following a hypoglycemia event.

Secondary Outcomes (1)

  • Measures of cognitive function following a hypoglycemic event

    Within 24 to 36 hours of a hypoglycemia event.

Other Outcomes (2)

  • Adverse events following a hypoglycemic event.

    Up to one year following the hypoglycemia event

  • Measure of cognitive function

    Within 24 to 36 hours of the index hypoglycemic event

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Non-critically ill hospitalized patients with a diagnosis of diabetes at time of admission using established ADA criteria or prior physician diagnosis who experience a documented episode of hypoglycemia, defined as a blood glucose \< 70 mg/dl. .

You may qualify if:

  • Diagnosis of diabetes
  • Non-critically ill hospitalized surgical and medical patients
  • Anticipated length of stay (LOS) \>3 days
  • Anticipated life expectancy \> 1 year
  • Mentally competent individuals

You may not qualify if:

  • Patients who are admitted for hypoglycemia or Diabetic Ketoacidosis
  • Anticipated LOS \<3 days
  • Mentally incompetent individuals defined as any patient with evidence of dementia or delirium recorded in their medical history or progress note
  • Patients receiving Total Parenteral Nutrition
  • Treatment with high dose narcotic medications
  • Patients who would not be able to follow up at 3 to 6 and 9-12 months by telephone call
  • Patients with expected life expectancy \< 1 year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh Medical Center PUH SSY

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Diabetes MellitusHypoglycemiaDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Cognition Disorders

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Mary T Korytkowski, MD

    University of Pittsburgh School of Medicine, Department of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

August 27, 2014

First Posted

August 29, 2014

Study Start

August 1, 2014

Primary Completion

December 1, 2015

Study Completion

March 1, 2016

Last Updated

September 7, 2018

Record last verified: 2018-09

Locations